In his final days at the helm of FDA, Commissioner Scott Gottlieb says the agency will consider a new regulatory framework for bringing medical devices to market that use advanced artificial intelligence algorithms.
Software - News
The Department of Homeland Security and FDA alerted people about cybersecurity vulnerabilities affecting Medtronic's implantable defibrillators. Medtronic is developing updates to further mitigate these vulnerabilities.
The company said it will sell its health information systems business unit to Philips. The deal is expected to close later this year.
A real-time platform that supports collaboration between acute-care and post-acute-care teams could allow users to monitor medical device procedure outcomes.
Co-developed by Medtronic and the recently acquired Mazor Robotics, the system represents a unique marriage between robotics and navigation.
ARGONet is an AI solution developed by researchers from the Computational Health Informatics Program at Boston Children’s Hospital, and results evaluating the method's effectiveness were published in Nature Communications.
An artificial intelligence solution that can identify precancerous changes in a woman’s cervix, comes on the heels of a Mayo Clinic Study that shows the percentage of women who are screened for cervical cancer could be far lower than national data suggests.
Medtronic has issued a software update to address cybersecurity vulnerabilities associated with the Internet connection between two models of CareLink programmers used to download software from the company's network.
The Redwood City, CA based company said that private information from about 1,100 individuals was exposed due to the cybersecurity attack.
4Dx has developed an algorithm-based software that converts X-ray images into more detailed airflow studies.
What happens when you put a former Nike designer, top clinicians, and biomedical engineers in a room with a blank sheet of paper and the goal of raising convenience for nurses and lowering healthcare costs?
The emergence of electronic healthcare records and recent advancements in computing technology have created the need for Apixio’s artificial intelligence solution.
MedAware finds a partner in Allscripts as it moves forward with commercialization efforts in the U.S.
LifePlus, which has been in stealth mode until now, is developing Lifeleaf, a non-invasive continuous blood glucose monitoring (CGM) multi-sensor wearable device.